Biosante Pharmaceuticals Inc (NASDAQ:BPAX)

CAPS Rating: 2 out of 5

A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.

Recs

0
Player Avatar JorgeAura (< 20) Submitted: 11/23/2012 9:06:08 AM : Outperform Start Price: $1.19 BPAX Score: +28.44

Undevalued. Strong cash position. Good partners.

Report this Post Reply

Featured Broker Partners


Advertisement